surmount-1 tirzepatide weight loss non-diabetic trial obesity without diabetes non- diabetic once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 SURMOUNT-1: Tirzepatide Drastically Comparison of Clinical Efficacy and
Pay in 4 interest-free payments of $6.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5

01200-X/asset/187876e5-369e-466d-8bb1-a92ee0475cd1/main.assets/gr3.jpg)


















